Sep 22, 2015 - Inovio Pharmaceuticals, Inc. (INO) announced that the U.S. Defense Advanced Research Projects Agency has exercised its option to provide an additional $24 million for the development of Inovio's multiple treatment and prevention approaches against Ebola.
Sep 22, 2015 - Companies in the News are:
Sep 21, 2015 - Merck & Co. Inc. (MRK) announced encouraging data from two pivotal phase III clinical studies for its investigational antitoxin bezlotoxumab for prevention of recurrence of Clostridium difficile infection.
Sep 09, 2015 - Tetraphase Pharmaceuticals (TTPH) announced that the IGNITE2 study on eravacycline for complicated urinary tract infections did not meet its primary endpoint.
Sep 03, 2015 - Incyte (INCY) signs an agreement with Hengrui to develop and commercialize an anti-PD-1 monoclonal antibody, SHR-1210.
Aug 28, 2015 - The Dow experienced one of its most eventful weeks in recent times, posting both record gains and record losses.
Aug 28, 2015 - The Zacks Analyst Blog Highlights: Merck & Co, Apple, Visa, Microsoft and Intel
Aug 27, 2015 - Novo Nordisk (NVO) announced that it intends to start the phase IIIa PIONEER program on once-daily oral semaglutide for the treatment of type II diabetes.
Aug 27, 2015 - This is the blue chip index's third largest gain in terms of points and the best since the crisis of 2008.
Aug 27, 2015 - Benchmarks scored a multi-record percentage gain on Wednesday following strong durable-goods report and comments from a Fed official that a September rate hike seems inappropriate